𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Myelopoietic abnormalities in patients with metastatic carcinoma

✍ Scribed by Yong K. Liu; Manuel Grimaldi; Charles L. Dannaher


Publisher
John Wiley and Sons
Year
1978
Tongue
English
Weight
513 KB
Volume
41
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Myelopoiesis was assessed in 41 untreated patients with widespread cancer without evidence of infection. None of these patients had neutropenia, although leukopenia due to decreased concentrations of blood lymphocytes was observed in two. Sixteen patients (39%) had neutrophilia and 12 patients (29%), 5 of them with neutrophilia, had decreased marrow granulocyte reserve. Neither the blood neutrophil counts nor the marrow granulocyte reserve correlated significantly with the marrow myeloid mitotic indices, myeloid to erythroid ratio or the number of marrow colony-forming cells. There was no difference in the duration of the disease, the extent of systemic metastasis and the degree of malnutrition between patients with or without myelopoietic abnormalities. Our findings suggest that decreased marrow granulocyte reserve and neutrophilia are common in untreated patients with disseminated carcinoma.


πŸ“œ SIMILAR VOLUMES


Metastatic patterns at autopsy in patien
✍ Uwe GΓΌth; Dorothy Jane Huang; Gregor Bauer; Marco Stieger; Edward Wight; Gad Sin πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 104 KB

## Abstract ## BACKGROUND. Previously published studies concerning autopsy findings in ovarian cancer failed to consider the broad differences in factors that influence the course of disease. Furthermore, those studies were conducted when the currently accepted standards in diagnostics and therapy

Fadrozole hydrochloride in postmenopausa
✍ Antonius A. Miller; Allan Lipton; I. Craig Henderson; Rudolph Navari; Mary T. Mu πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 471 KB πŸ‘ 2 views

## BACKGROUND. Fadrozole hydrochloride (CGS-16949A) belongs to the class of aromatase inhibitors that lowers circulating estrogen levels by inhibiting the conversion of androgens to estrogens, thereby causing tumor regression in patients with breast carcinoma. METHODS. This was a prospective, ran

Predictors of skeletal complications in
✍ Susan M. Domchek; Jerry Younger; Dianne M. Finkelstein; Michael V. Seiden πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 2 views

## Background: The high rate of incidence of skeletal complications in women with metastatic breast carcinoma appears to contribute significantly to their morbidity. although recent trials have demonstrated the efficacy of bisphosphonates in preventing skeletal complications in selected patients, t